The Contraceptives Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Contraceptives Global Market has seen substantial growth recently. The market size is projected to increase from $27.92 billion in 2024 to $30.05 billion in 2025. This growth corresponds to a compound annual growth rate (CAGR) of 7.6%.
The Contraceptives Global Market is projected to reach $40.89 billion in 2029, with a compound annual growth rate (CAGR) of 8.0%.
Download Your Free Sample of the 2025 Contraceptives Market Report and Uncover Key Trends Now!The key drivers in the contraceptives market are:
• Growing focus and development of male contraceptives
• Increased accessibility of contraception methods in developing nations
• Integration of digital health technologies in contraceptive methods
• Rising demand for long-acting reversible contraceptives and enhancement of online availability for over-the-counter drugs.
The contraceptives market covered in this report is segmented –
1) By Product: Oral Contraceptive Pills, Topical Contraceptives, Injectables, Diaphragms, Vaginal Rings, Condoms, Contraceptive Sponges, Subdermal Implants, Intra-Uterine Devices
2) By Age Group: 15-24 Years, 25-34 Years, 35-44 Years, 44 Years
3) By Distribution Channel: Hospital Pharmacies, Independent Pharmacies, Online Pharmacies, Clinics, Other Distribution Channels
The key trends in the incident and emergency management market are:
• Technological advancements in contraceptive methods is a major forthcoming trend.
• There is a visible shift towards non-hormonal and natural contraceptive methods.
• The contraceptive market is witnessing expansion in over-the-counter access to certain products.
• An emphasis on user-friendly and discreet contraceptive options as well as integration of telemedicine in contraceptive counseling and prescriptions are shaping the future of the market.
Major companies in the contraceptives market are:
• Merck & Co. Inc.
• Bayer AG
• Church & Dwight Co. Inc.
• Cipla Inc.
• Reckitt Benckiser Group plc
• Agile Therapeutics Inc.
• Allergan Ltd.
• Aurobindo Pharma Limited
• Famy Care Ltd.
• Glenmark Pharmaceuticals Limited
• HLL Lifecare Limited
• Johnson & Johnson
• Laboratoire HRA Pharma SAS
• Lupin Limited
• Mankind Pharma Ltd.
• Mayer Laboratories Inc.
• Medisafe Distribution Inc.
• Mithra Pharmaceuticals SA
• Mylan NV
• Okamoto Industries Inc.
• Pfizer Inc.
• Pregna International Ltd.
• Syncom Pharmaceuticals
• Teva Pharmaceutical Industries Ltd.
• The Population Council
• Veru Inc.
• Zydus Cadila
• Shanghai Dahua Pharmaceutical Co. Ltd.
• Sichuan Kangdi Pharmaceutical Co. Ltd.
• Beijing Zhengyuan Pharmaceutical Co. Ltd.
• Zhejiang Huahai Pharmaceutical Co. Ltd.
• Chongqing Pharmaceutical Group Co. Ltd.
North America was the largest region in the contraceptives market in 2024 and is expected to be the fastest-growing region in the forecast period